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Long-term survival after resection of isolated adrenal
metastatic was ﬁrst reported in 1982 by Twomey
et al.
1 Their two patients were disease-free for 6 and
14 years after resection of an isolated adrenal
metastasis from large-cell lung cancer. Since then,
many series, including several from the Memorial
Sloan-Kettering Cancer Center, have conﬁrmed that
when metastasis is isolated to the adrenal gland,
adrenalectomy can achieve long-term survival. In
‘‘Laparoscopic Adrenalectomy for Isolated Adrenal
Metastasis’’, Strong et al.
2 updated the results of the
series from Memorial Sloan-Kettering Cancer Cen-
ter, last published in 2003 with 41 patients and 11
laparoscopic adrenalectomies.
3,4 The current report
of 94 adrenalectomies (31 laparoscopic) in 92 patients
more than doubled their previous report and is the
largest series published to date to addresses this issue.
So what is new? With such a large number of pa-
tients, Strong et al. were able to more deﬁnitively
compare the results of laparoscopic adrenalectomy
versus open adrenalectomy. They showed that lapa-
roscopic adrenalectomy, compared with open adre-
nalectomy, resulted in less morbidity and achieved
similar oncological outcomes.
It is not surprising that laparoscopic resection re-
sults in less morbidity; there is less blood loss, fewer
complications, and a shorter hospital stay. These
ﬁndings are consistent with other smaller series
5–8
and are consistent with the results of other types of
laparoscopic operations compared with open opera-
tions, including cholecystectomy, splenectomy,
nephrectomy, and colectomy. One potential con-
founding variable in this study is the size of tumor;
the mean size of tumor was 3.8 cm for the laparo-
scopic adrenalectomy group versus 6.4 cm for the
open adrenalectomy group. The authors addressed
this potential problem by a subgroup analysis limit-
ing the comparison to only patients with tumors
<4.5 cm. This subgroup analysis showed that the
advantages of laparoscopic resection persisted, so
smaller-size tumors did not explain the better results
of laparoscopic operation. The shorter operation
time for laparoscopic resection—almost half an hour
shorter than for open resection—most likely reﬂected
the experience of the Memorial Sloan-Kettering sur-
geons, who were already beyond their initial learning
curve for laparoscopic adrenalectomy.
When operating for cancers, the most important
concern for patients and surgeons is whether lapa-
roscopic resection can achieve the same oncological
outcomes as the more morbid open resection. In the
case of laparoscopic adrenalectomy, the outcomes
that could potentially be aﬀected are the risk of local
recurrence and the chance of long-term survival. In
this series, neither was adversely aﬀected by laparo-
scopic adrenalectomy. The local recurrence rates of
11% for laparoscopic adrenalectomy and 21% for
open adrenalectomy are not diﬀerent than other
series that showed either no local recurrences
5,6 or a
local regional recurrence rate of about 20%
7,8 after
laparoscopic resection for an isolated adrenal
metastasis. Port-site recurrence is rare,
9 and there
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3288were none in this study. Overall, the risk of local or
port site recurrence is much lower after laparoscopic
adrenalectomy for metastasis than that for primary
adrenal cortical cancer. This is likely the result of
different cancer biology and the more central location
and ﬁrmer consistency of adrenal metastases, making
it less likely that the laparoscopic surgeon will breach
the capsular and rupture the tumor.
One interesting ﬁnding in this series is that the
best independent predictor of patient survival was
smaller tumor size. Long-term survival rate was
twice as high for patients with metastases <4.5 cm
than for those with metastases >4.5 cm (58% vs.
29% for 3-year survival and 40% vs. 22% for 5-year
survival). Tumor size tends to predict survival in
many primary cancers; why it should also predict
survival in patients with isolated adrenal metastasis
is not clear. Do the smaller metastases reﬂect less
aggressive cancer or just earlier discovery? We do
not know.
Another interesting ﬁnding in this series is that the
disease-free interval between the discovery of primary
cancer and the development of metastasis was not a
predictor for survival. This is in contrast to the con-
clusion drawn from their previous smaller series,
which showed that patients with metachronous
metastasis had better survival than those with syn-
chronous metastasis.
3 Perhaps the current, more
sensitive imaging studies helped exclude most patients
with extra-adrenal metastases who would be expected
to have a poorer prognosis.
It is now 25 years after the ﬁrst report of long-term
survival after resection of isolated adrenal metastasis
and 15 years after the ﬁrst description of laparoscopic
adrenalectomy. This study by Strong et al. shows us
that adrenalectomy for isolated adrenal metastasis is
the right thing to do, and that laparoscopic adrenal-
ectomy is the right way to do it.
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